siRNA, Anti-BPHL, 2'-MOE/Ribo/Backbone-modified(CAT#: SIRGT03449WQ-2MOE)

The product SIRGT03449WQ-2MOE is a type of small interfering RNA (siRNA) that targets BPHL gene and regulates the expression of gene. The siRNA interferes with the expression of BPHL gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2'-O-methoxyethyl (2'-MOE) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001302777.1; NM_004332.3
Alternative Names BPH-RP; MCNAA; VACVASE
Related Diseases Zika Fever, Cardiomyopathy
Purification HPLC
Target Gene
Gene ID 670
Uniprot ID Q86WA6
Sub Cat Target Species Modification Scale  
SIRGT01449WQ-RB BPHL Human Ribo-modified Inquiry
SIRGT02449WQ-BB BPHL Human Backbone-modified Inquiry

Related Products